| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.068 | 0.2 |